3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
51
Fallopian Tube Neoplasms
28
Ovarian Neoplasms
23
Carcinoma, Non-Small-Cell Lung
22
Triple Negative Breast Neoplasms
15
Pancreatic Neoplasms
13
Breast Neoplasms, Male
11
Lung Neoplasms
10
Brenner Tumor
10
Inflammatory Breast Neoplasms
7
Uterine Cervical Neoplasms
5
Endometrial Adenocarcinoma
5
Adenocarcinoma of Lung
5
Urinary Bladder Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Melanoma
4
Cholangiocarcinoma
4
Carcinoma, Ovarian Epithelial
4
Adenocarcinoma, Bronchiolo-Alveolar
4
Adenocarcinoma Of Esophagus
4
Pleural Effusion, Malignant
3
Pancreatic Adenocarcinoma
3
Neoplasms
3
Thymoma
2
Neurotoxicity Syndromes
2
Gallbladder Neoplasms
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Carcinosarcoma
2
Breast Carcinoma In Situ
2
Interventions
Gemcitabine
6
Irinotecan
4
130-nm albumin-bound paclitaxel
4
Cisplatin
3
Albumin-Bound Paclitaxel
3
napabucasin
2
Leucovorin
2
Imatinib Mesylate
2
Everolimus
2
Ascorbic Acid
2
spartalizumab
1
pralsetinib
1
pembrolizumab
1
dostarlimab
1
copanlisib
1
alectinib
1
Ramucirumab
1
Paclitaxel
1
NUC-1031
1
Levoleucovorin
1
KRN-330
1
HhAntag691
1
Fluorouracil
1
Cyclophosphamide
1
Capecitabine
1
Bevacizumab
1
5,10-methylenetetrahydrofolic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Digestive System Neoplasms
×
Taxes
×
Clear all
No trials found.